tradingkey.logo

GeneDx Holdings Corp

WGS

126.360USD

+3.480+2.83%
Fechamento 08/15, 16:00ETCotações atrasadas em 15 min
3.63BValor de mercado
PerdaP/L TTM

GeneDx Holdings Corp

126.360

+3.480+2.83%
Mais detalhes de GeneDx Holdings Corp Empresa
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Informações da empresa
Código da empresaWGS
Nome da EmpresaGeneDx Holdings Corp
Data de listagemSep 04, 2020
CEOMs. Katherine A. Stueland
Número de funcionários1000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 04
Endereço333 Ludlow Street
CidadeSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Telefone18887291206
Sitehttps://sema4.com/
Código da empresaWGS
Data de listagemSep 04, 2020
CEOMs. Katherine A. Stueland
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
Distribuição de ações
Atualizado em: há 2 horas
Atualizado em: há 2 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Casdin Capital, LLC
12.21%
Corvex Management LP
10.65%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
OPKO Health Inc
4.77%
Outro
61.91%
Investidores
Investidores
Proporção
Casdin Capital, LLC
12.21%
Corvex Management LP
10.65%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
OPKO Health Inc
4.77%
Outro
61.91%
Tipos de investidores
Investidores
Proporção
Investment Advisor
34.86%
Hedge Fund
34.61%
Investment Advisor/Hedge Fund
32.44%
Corporation
10.71%
Research Firm
5.56%
Individual Investor
1.75%
Pension Fund
1.22%
Bank and Trust
0.42%
Sovereign Wealth Fund
0.29%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Casdin Capital, LLC
3.53M
12.36%
--
--
May 05, 2025
Corvex Management LP
2.91M
10.19%
+434.85K
+17.58%
May 05, 2025
William Blair Investment Management, LLC
1.19M
4.17%
+518.99K
+77.46%
Mar 31, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.81%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.8%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.04M
3.64%
-41.94K
-3.89%
Mar 31, 2025
The Vanguard Group, Inc.
1.03M
3.6%
+23.46K
+2.34%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
503.73K
1.77%
+503.73K
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qua, 6 de ago
Atualizado em: qua, 6 de ago
Nome
Proporção
Global X Genomics & Biotechnology ETF
3.13%
Innovator IBD 50 Fund ETF
3.09%
SPDR S&P Health Care Services ETF
2.64%
Harbor Health Care ETF
1.75%
Franklin Genomic Advancements ETF
1.19%
Simplify Health Care ETF
1.03%
Hypatia Women CEO ETF
0.78%
Fidelity Enhanced Small Cap ETF
0.67%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
First Trust Active Factor Small Cap ETF
0.51%
Ver Mais
Global X Genomics & Biotechnology ETF
Proporção3.13%
Innovator IBD 50 Fund ETF
Proporção3.09%
SPDR S&P Health Care Services ETF
Proporção2.64%
Harbor Health Care ETF
Proporção1.75%
Franklin Genomic Advancements ETF
Proporção1.19%
Simplify Health Care ETF
Proporção1.03%
Hypatia Women CEO ETF
Proporção0.78%
Fidelity Enhanced Small Cap ETF
Proporção0.67%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.57%
First Trust Active Factor Small Cap ETF
Proporção0.51%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Data
Tipo
Proporção
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
KeyAI